A multicenter phase II study of eribulin in patients with BRAF V600E mutant metastatic colorectal cancer: BRAVERY study (EPOC1701)T. Masuishi,H. Taniguchi,D. Kotani,H. Bando,Y. Komatsu,E. Shinozaki,T. Nakajima,T. Satoh,T. Nishina,T. Esaki,M. Wakabayashi,S. Nomura,K. Takahashi,H. Ono,N. Hirano,N. Fujishiro,N. Fuse,A. Sato,A. Ohtsu,T. YoshinoANNALS OF ONCOLOGY（2020）引用 3|浏览25暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
